Abstract:Compared to the conventional anti-cancer drugs, the nano-drug delivery systems (NDDS) shows a comparatively ideal therapeutic efficacy ascribing their high tumor-target capacity and efficient drug release ability. In this study, a novel macromolecular prodrug conjugate was designed and developed that is passively triggered by the acidic environment of the tumor cells and can release doxorubicin (Dox). The susceptibility of the system to the acidic environment is due to the acid volatile Schiff base covalent bond between grafted carboxymethyl chitosan (CMCs) and Dox. The chemical structure of the finalized system was characterized by 1H-NMR spectroscopy. Because of the hydrophobicity of the Dox and the hydrophilicity of the CMCs, the amphipathic polymeric drug conjugates can self-assemble into the nanoparticles in aqueous solution. The morphology and size of the nanoparticles were observed with TEM (transmission electron microscopy) and DLS (dynamic light scattering). The in vitro drug release studies demonstrated that the drug release rate of the prodrug were visibly higher in acidic conditions (pH 5.0) compared to higher pHs like 6.5 and 7.4. DLS results showed that the mean size of the prodrug nanoparticles increased as the pH of the solution decreased from 7.4 to 6.5 and 5.0. Furthermore, the cell counting kit-8 (CCK-8) assays showed that the polymeric drug nanoparticles had a cytotoxic effect on SKOV3 ovarian cancer cells while the segments of the DDS revealed comparatively lower cytotoxic effect. Moreover, confocal laser scanning microscopy (CLSM) showed that the prodrug could efficiently deliver and release Dox in the nuclei of the cancer cells while this was not observed for the Dox pure drug. These results proved that the carboxymethyl chitosan-CBA-Doxorubicin NPs have superior stabilities, low toxicities, proper sizes, and enhanced curable efficiency for in vitro controlled release. Thus, this pH-sensitive prodrug could be a potential treatment for cancer therapy in the near future.

Ph-Sensitive Chitosan-Derived Nanoparticles As Doxorubicin Carriers for Effective Anti-Tumor Activity: Preparation and in Vitro Evaluation.

Synthesis and in Vitro Characterization of Carboxymethyl Chitosan-CBA-Doxorubicin Conjugate Nanoparticles As Ph-Sensitive Drug Delivery Systems

Dually Responsive Nanoparticles for Drug Delivery Based on Quaternized Chitosan

Synthesis and Evaluation of Ph-Sensitive, Self-Assembled Chitosan-Based Nanoparticles As Efficient Doxorubicin Carriers

A Ph-Sensitive Nanosystem Based on Carboxymethyl Chitosan for Tumor-Targeted Delivery of Daunorubicin.

Dual-pH responsive chitosan nanoparticles for improving in vivo drugs delivery and chemoresistance in breast cancer

Efficient Fabrication of Reversible Ph-Induced Carboxymethyl Chitosan Nanoparticles for Antitumor Drug Delivery under Weakly Acidic Microenvironment.

Chitosan/o-carboxymethyl Chitosan Nanoparticles for Efficient and Safe Oral Anticancer Drug Delivery: in Vitro and in Vivo Evaluation.

Polymeric nanoparticles of cholesterol-modified glycol chitosan for doxorubicin delivery: preparation and in-vitro and in-vivo characterization.

Enhanced Cellular Internalization and On-Demand Intracellular Release of Doxorubicin by Stepwise Ph-/Reduction-responsive Nanoparticles.

Ph-Sensitive Amphiphilic Chitosan-Quercetin Conjugate for Intracellular Delivery of Doxorubicin Enhancement

Ph-Responsive Core-Shell Structured Nanoparticles for Triple-Stage Targeted Delivery of Doxorubicin to Tumors

Hybrid Nanoparticles Based on Ortho Ester-Modified Pluronic L61 and Chitosan for Efficient Doxorubicin Delivery

A pH-responsive chitosan-b-poly(p-dioxanone) nanocarrier: formation and efficient antitumor drug delivery.

Zwitterionic Ph-Responsive Hyaluronic Acid Polymer Micelles for Delivery of Doxorubicin.

Preparation of Ph-Sensitive Doxorubicin Liposomes Modified with Carboxymethyl Chitosan and in Vitro Cell Research

Ph-Sensitive Deoxycholic Acid Dimer for Improving Doxorubicin Delivery and Antitumor Activity in Vivso.

Chitosan functionalized doxorubicin loaded poly(methacrylamide) based copolymeric nanoparticles for enhanced cellular internalization and in vitro anticancer evaluation

Nanoparticles of deoxycholic acid, polyethylene glycol and folic acid-modified chitosan for targeted delivery of doxorubicin

Synthesis and characterization of amphiphilic glycidol-chitosan-deoxycholic acid nanoparticles as a drug carrier for doxorubicin.

Ph-Sensitive Nanoparticles Based on Amphiphilic Imidazole/cholesterol Modified Hydroxyethyl Starch for Tumor Chemotherapy